ClinicalTrials.govpublic full text
Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC
non-small cell lung cancer, recurrent, nsclc, pembrolizumab, sbrt, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879111
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.